Heterogeneity in Excess Mortality Across Mental, Behavioural, and Neurodevelopmental Disorders

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Importance

Excess mortality associated with mental disorders is well established, but estimates are largely based on specialist psychiatric populations. Whether they characterize mortality in the broader diagnosed population is uncertain.

Objective

To characterize heterogeneity in excess mortality by diagnosis, psychiatric care setting, substance use disorder (SUD), and time since diagnosis.

Design

Nationwide population-based cohort study with follow-up from January 1, 2011, through December 31, 2023.

Setting

Primary and specialist health care and population registers in Finland.

Participants

Residents aged 5 to 95 years without a recorded prevalent mental disorder at cohort entry.

Exposures

Mental, behavioural, and neurodevelopmental disorders classified using ICD-11, with time-varying psychiatric care setting and SUD status.

Main Outcomes and Measures

All-cause mortality, mortality rate ratios (MRRs), and 10-year differences in restricted mean survival time (RMST).

Key Points

Question

Does excess mortality associated with mental disorders vary by diagnosis, clinical context, and time since diagnosis?

Findings

In this nationwide cohort study of 5.5 million individuals, excess mortality varied markedly by diagnosis, psychiatric care setting, comorbid substance use disorder, and time since diagnosis. For the 3 most common diagnostic groups, mortality approached that of individuals without the diagnosis during follow-up among those without substance use disorder treated outside specialist psychiatric care, whereas excess mortality persisted for psychotic disorders and higher-risk clinical subgroups.

Meaning

Excess mortality is not a uniform feature of mental disorder diagnosis; estimates derived from specialist psychiatric populations or averaged across follow-up may provide an incomplete picture of mortality in the broader diagnosed population.

Results

Among 5,526,599 individuals (2,784,897 [50.4%] women), 1,463,064 (26.5%) received a mental disorder diagnosis. Excess mortality varied substantially by diagnosis, clinical subgroup, and time since diagnosis. Among those aged 5 to 64 years with any mental disorder, adjusted MRRs across care setting and SUD strata ranged from 1.54 (95% CI, 1.39–1.71) to 8.97 (7.86–10.24). MRRs were highest immediately after first diagnosis and declined during the first 2 to 3 years. At 3 years, MRRs for depressive, anxiety or fear-related, and stress-related disorders among individuals without SUD treated outside specialist psychiatric care ranged from 0.88 (0.79–0.98) to 1.20 (1.12–1.29) in men and from 0.81 (0.73–0.89) to 1.13 (1.04–1.22) in women, whereas MRRs for schizophrenia andother primary psychotic disorders remained 1.84 (1.60–2.12) in men and 1.55 (1.37–1.75) in women. Ten-year survival loss across all mental disorders was 0.53 years (95% CI, 0.53– 0.54) in men and 0.34 years (0.33–0.34) in women and was greater for natural than external causes.

Conclusions and Relevance

Excess mortality varied markedly by diagnosis, clinical context, and time since diagnosis and was small in some common disorders outside specialist psychiatric care without SUD. Estimates derived from specialist psychiatric populations or averaged across follow-up may therefore provide an incomplete picture of mortality in the broader diagnosed population.

Article activity feed